Integra Lifesciences Holdings Corp (NASDAQ: IART) is -49.18% lower on its value in year-to-date trading and has touched a low of $16.81 and a high of $45.42 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IART stock was last observed hovering at around $22.01 in the last trading session, with the day’s gains setting it 0.12%.
Currently trading at $22.13, the stock is -6.12% and -1.84% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.13 million and changing 0.55% at the moment leaves the stock -13.35% off its SMA200. IART registered -50.37% loss for a year compared to 6-month loss of -22.54%. The firm has a 50-day simple moving average (SMA 50) of $22.4866 and a 200-day simple moving average (SMA200) of $25.61105.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -6.15% gain in the last 1 month and extending the period to 3 months gives it a 29.11%, and is -3.91% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.95% over the week and 3.31% over the month.
Integra Lifesciences Holdings Corp (IART) has around 5329 employees, a market worth around $1.72B and $1.56B in sales. Fwd P/E is 8.80. Profit margin for the company is -0.42%. Distance from 52-week low is 31.69% and -51.28% from its 52-week high. The company has generated returns on investments over the last 12 months (-0.23%).
with sales reaching $445.15M over the same period.The EPS is expected to shrink by -20.92% this year, but quarterly earnings will post 4.64% year-over-year. Quarterly sales are estimated to grow 12.12% in year-over-year returns.
Integra Lifesciences Holdings Corp (IART) Top Institutional Holders
323.0 institutions hold shares in Integra Lifesciences Holdings Corp (IART), with institutional investors hold 96.21% of the company’s shares. The shares outstanding are 77.13M, and float is at 66.12M with Short Float at 5.22%. Institutions hold 93.13% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 11.25 million shares valued at $327.92 million. The investor’s holdings represent 14.4766% of the IART Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 7.77 million shares valued at $226.5 million to account for 9.999 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 5.5 million shares representing 7.0734% and valued at over $160.23 million, while WELLINGTON MANAGEMENT GROUP LLP holds 4.9997 of the shares totaling 3.89 million with a market value of $113.25 million.
Integra Lifesciences Holdings Corp (IART) Insider Activity
The most recent transaction is an insider sale by Schwartz Eric, the company’s EVP, Chief Legal Officer & Sec. SEC filings show that Schwartz Eric sold 4,070 shares of the company’s common stock on Dec 03 ’24 at a price of $24.59 per share for a total of $0.1 million. Following the sale, the insider now owns 59511.0 shares.
Still, SEC filings show that on Dec 02 ’24, McBreen Michael J. (EVP & President, CSS) disposed off 1,700 shares at an average price of $24.16 for $41064.0. The insider now directly holds 56,182 shares of Integra Lifesciences Holdings Corp (IART).
